Family

Loading Family data...

• 15 United States
• 10 France
• 8 Japan
• 7 China
• 5 Korea
• 2 Other

Patent Owner(s)

Patent Owner	Address
CHARGEPOINT TECHNOLOGY LIMITED	LIVERPOOL L24 9PB

International Classification(s)

• F16K:VALVES; TAPS; COCKS; ACTUATING-FLOATS; DEVICES FOR....

• 2010 Application Filing Year
• F16K Class
• 1233 Applications Filed
• 809 Patents Issued To-Date
• 65.62 % Issued To-Date

Inventor(s)

Inventor Name	Address	# of filed Patents	Total Citations
Barton, Richard Athol	Manchester, GB	9	122
# of filed Patents : 9 Total Citations : 122

Cited Art Landscape

Load Citation

• No Cited Art to Display

Loading Cited Art Landscape...

Patent Citation Ranking

• 5 Citation Count
• F16K Class

• 11.92 % this patent is cited more than
• 11 Age

Forward Cite Landscape

Load Citation

• No Forward Cites to Display

Loading Forward Cite Landscape...

Maintenance Fees

Fee	Large entity fee	small entity fee	micro entity fee	due date
11.5 Year Payment	$7400.00	$3700.00	$1850.00	Dec 3, 2025

Fee	Large entity fee	small entity fee	micro entity fee
Surcharge - 11.5 year - Late payment within 6 months	$160.00	$80.00	$40.00
Surcharge after expiration - Late payment is unavoidable	$700.00	$350.00	$175.00
Surcharge after expiration - Late payment is unintentional	$1,640.00	$820.00	$410.00

DATE PUBLISHED	PUBLICATION/PATENT NO.	PUBLICATION TYPE
June 03, 2014	US,8740187,B2   US8740187B2	GRANTED PATENT AS SECOND PUBLICATION
May 10, 2012	US,20120112108,A1   US20120112108A1	FIRST PUBLISHED PATENT APPLICATION

Full Text

US Patent No: 9687493

Use of NK-1 receptor antagonists for treating hypomagnesemia, neurogenic inflammation, and cardiac dysfunction associated with EGFR-blocking drugs

---

Abstract

---

The present disclosure provides methods for alleviating or preventing the negative physiological side effects associated with the administration of EGFR blocking therapeutics. The disclosure provides, inter alia, methods for treating or preventing: hypomagnesemia, cardiac dysfunction, and skin lesions, which are induced by EGFR blocking drugs, by administering an NK-1 receptor antagonist.

---

 

---

Description

---

Claims

---

Claims data not available

---

Legal Events

 

• MAFP2024
• MAFP2020
• I2017
• STCF2017
• AS2017
• P2017
• F2016
• AS2015

Date	Code	Event	Description
Dec 27, 2024	MAFP	MAINTENANCE FEE PAYMENT	free format text: PAYMENT OF MAINTENANCE FEE, 8TH YR, SMALL ENTITY (ORIGINAL EVENT CODE: M2552); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY year of fee payment: 8
Dec 28, 2020	MAFP	MAINTENANCE FEE PAYMENT	free format text: PAYMENT OF MAINTENANCE FEE, 4TH YR, SMALL ENTITY (ORIGINAL EVENT CODE: M2551); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY year of fee payment: 4
Jun 27, 2017	I	Issuance
Jun 07, 2017	STCF	INFORMATION ON STATUS: PATENT GRANT	free format text: PATENTED CASE
Feb 01, 2017	AS	ASSIGNMENT	free format text: CONFIRMATORY LICENSE;ASSIGNOR:GEORGE WASHINGTON UNIVERSITY;REEL/FRAME:041628/0147 Owner name: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF Effective Date: Feb 01, 2017
Jan 19, 2017	P	Published
Sep 28, 2016	F	Filing
Jul 08, 2015	AS	ASSIGNMENT	free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:WEGLICKI, WILLIAM B.;MAK, IU TONG;REEL/FRAME:041657/0460 Owner name: THE GEORGE WASHINGTON UNIVERSITY, DISTRICT OF COLU Effective Date: Jul 08, 2015